Keel Point’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$474K Buy
5,564
+388
+7% +$34.6K 0.03% 274
2025
Q4
$409K Sell
5,176
-463
-8% -$36.3K 0.02% 342
2025
Q3
$451K Buy
5,639
+1,023
+22% +$87.3K 0.03% 322
2025
Q2
$420K Buy
4,616
+193
+4% +$17.6K 0.03% 332
2025
Q1
$414K Buy
4,423
+545
+14% +$48.8K 0.03% 290
2024
Q4
$353K Sell
3,878
-297
-7% -$28.3K 0.03% 296
2024
Q3
$433K Sell
4,175
-37
-0.9% -$3.77K 0.04% 262
2024
Q2
$424K Buy
+4,212
New +$389K 0.04% 261

Other funds holding CL

Keel Point's CL Position: Q1 2026 in Review

Keel Point increased its Colgate-Palmolive (CL) stake by 7.5% in Q1 2026, buying an estimated $34.6K and bringing the position to 5,564 shares worth $474K. The position accounts for 0.03% of the portfolio, ranked #274.

Keel Point first reported a position in CL in Q2 2024 and has held it in 8 quarters since. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Keel Point held 5,564 shares of Colgate-Palmolive worth $474K as of Q1 2026.
  • Keel Point bought 388 Colgate-Palmolive shares in Q1 2026, an estimated $34.6K.
  • Colgate-Palmolive made up 0.03% of Keel Point's portfolio in Q1 2026, its #274 holding.
  • Keel Point first reported a position in Colgate-Palmolive in Q2 2024 and has held it in 8 quarters since.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Keel Point's 13F filing for Q1 2026, filed 1 Jun 2026.